| Dr Justin Scott Reid, MD | |
|
4802 S 109th East Ave, Tulsa, OK 74146-5822 | |
| (918) 392-1400 | |
| (918) 392-1401 |
| Full Name | Dr Justin Scott Reid |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 19 Years |
| Location | 4802 S 109th East Ave, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124221262 | NPI | - | NPPES |
| 200588760A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 14311 (Hawaii) | Secondary |
| 207XS0114X | Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery | 29032 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Complete Home Health Of Western Oklahoma | Enid, OK | Home health agency |
| Tulsa Spine & Specialty Hospital | Tulsa, OK | Hospital |
| Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tulsa Bone And Joint Associates Pc | 9335033802 | 70 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.
The U.S. Food and Drug Administration today approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing surgery to remove tumor-draining lymph nodes.
An increase in overall hospitalizations was reported for older adults in the week following exposure to a tropical cyclone, according to a new study by researchers at Columbia University Mailman School of Public Health, Columbia University's Earth Institute and colleagues at Colorado State University and Harvard T. H. Chan School of Public Health.
Shopping to update your coverage on the health insurance marketplace may be annoying — didn't you just do this last year? But letting the exchange automatically renew your coverage instead could be a big mistake.
Mycobacterium tuberculosis is arguably the world's most successful infectious agent because it knows how to avoid elimination by slowing its own growth to a crawl. Now, a report in the July 10 issue of the journal Cell, a Cell Press publication, offers new insight into the bugs' talent for meager living.
› Verified 6 days ago
| Entity Name | Tulsa Bone & Joint Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154373132 PECOS PAC ID: 9335033802 Enrollment ID: O20040214000207 |
News Archive
miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.
The U.S. Food and Drug Administration today approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing surgery to remove tumor-draining lymph nodes.
An increase in overall hospitalizations was reported for older adults in the week following exposure to a tropical cyclone, according to a new study by researchers at Columbia University Mailman School of Public Health, Columbia University's Earth Institute and colleagues at Colorado State University and Harvard T. H. Chan School of Public Health.
Shopping to update your coverage on the health insurance marketplace may be annoying — didn't you just do this last year? But letting the exchange automatically renew your coverage instead could be a big mistake.
Mycobacterium tuberculosis is arguably the world's most successful infectious agent because it knows how to avoid elimination by slowing its own growth to a crawl. Now, a report in the July 10 issue of the journal Cell, a Cell Press publication, offers new insight into the bugs' talent for meager living.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Justin Scott Reid, MD 4802 S 109th East Ave, Tulsa, OK 74146-5822 Ph: (918) 392-1400 | Dr Justin Scott Reid, MD 4802 S 109th East Ave, Tulsa, OK 74146-5822 Ph: (918) 392-1400 |
News Archive
miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.
The U.S. Food and Drug Administration today approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing surgery to remove tumor-draining lymph nodes.
An increase in overall hospitalizations was reported for older adults in the week following exposure to a tropical cyclone, according to a new study by researchers at Columbia University Mailman School of Public Health, Columbia University's Earth Institute and colleagues at Colorado State University and Harvard T. H. Chan School of Public Health.
Shopping to update your coverage on the health insurance marketplace may be annoying — didn't you just do this last year? But letting the exchange automatically renew your coverage instead could be a big mistake.
Mycobacterium tuberculosis is arguably the world's most successful infectious agent because it knows how to avoid elimination by slowing its own growth to a crawl. Now, a report in the July 10 issue of the journal Cell, a Cell Press publication, offers new insight into the bugs' talent for meager living.
› Verified 6 days ago
Dr. Jaclyn Cinda Jones, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1245 S Utica Ave, Tulsa, OK 74104 Phone: 918-579-2590 Fax: 918-579-2599 | |
James F Bischoff, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2448 E 81st St Ste 1200, Tulsa, OK 74137 Phone: 918-900-6432 Fax: 918-392-7057 | |
Rodney L Plaster, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2448 E 81st St Ste 1520, Tulsa, OK 74137 Phone: 918-900-2520 Fax: 918-900-2521 | |
Dr. Wesley M Stotler, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4802 S 109th East Ave, Tulsa, OK 74146 Phone: 918-392-1400 Fax: 918-392-1488 | |
David R. Hicks, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6585 S Yale Ave Ste 200, Tulsa, OK 74136 Phone: 918-481-2767 Fax: 918-494-9277 | |
Sami Rumi Framjee, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2000 S Wheeling Ave, Suite 1110, Tulsa, OK 74104 Phone: 918-742-7339 Fax: 918-742-2119 | |
Mark Steven Schwartz, D.O. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 6465 S Yale Ave, Suite 420, Tulsa, OK 74136 Phone: 918-502-8810 |